Is There a Role of Targeted Agents in the Management of Adrenocortical Cancers?
Background. Adrenocortical carcinoma (ACC) is a rare and aggressive tumor arising from the adrenal cortex with an incidence of one to two cases per million within the general US population. Recent developments in the understanding of the pathogenesis of ACC have led to multiple clinical trials invol...
Saved in:
Main Authors: | M. W. Saif, B. Fallon, K. N. Syrigos |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Case Reports in Endocrinology |
Online Access: | http://dx.doi.org/10.1155/2012/875764 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of Vitamin D in the Prevention of Pancreatic Cancer
by: Pubudu Bulathsinghala, et al.
Published: (2010-01-01) -
Desmoplasia in Pancreatic Cancer. Can We Fight It?
by: E. E. Merika, et al.
Published: (2012-01-01) -
Was It an Adrenocortical Adenoma or an Adrenocortical Carcinoma? Limitation of the Weiss Scoring System in Determining the Malignant Potential of Adrenocortical Tumor: Report on Two Cases
by: Cheuk-Lik Wong, et al.
Published: (2022-01-01) -
Adrenocortical Causes of Hypertension
by: Andreas Moraitis, et al.
Published: (2011-01-01) -
Benign Adrenocortical Tumors and the Detection of Nonadrenal Neoplasia
by: Meng Hao, et al.
Published: (2019-01-01)